KR20210147707A - Composition for relieving and preventing hangover comprising Oenanthe javanica extracts - Google Patents
Composition for relieving and preventing hangover comprising Oenanthe javanica extracts Download PDFInfo
- Publication number
- KR20210147707A KR20210147707A KR1020200065336A KR20200065336A KR20210147707A KR 20210147707 A KR20210147707 A KR 20210147707A KR 1020200065336 A KR1020200065336 A KR 1020200065336A KR 20200065336 A KR20200065336 A KR 20200065336A KR 20210147707 A KR20210147707 A KR 20210147707A
- Authority
- KR
- South Korea
- Prior art keywords
- water
- extract
- relieving
- isoramnetine
- hangover
- Prior art date
Links
- 206010019133 Hangover Diseases 0.000 title claims abstract description 35
- 239000000203 mixture Substances 0.000 title claims abstract description 25
- 239000000284 extract Substances 0.000 title claims abstract description 23
- 230000003405 preventing effect Effects 0.000 title claims abstract description 15
- 240000008881 Oenanthe javanica Species 0.000 title abstract description 8
- 235000000365 Oenanthe javanica Nutrition 0.000 title abstract description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 57
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000002904 solvent Substances 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 15
- 238000004519 manufacturing process Methods 0.000 claims abstract description 10
- 240000006243 Oenanthe sarmentosa Species 0.000 claims description 69
- 235000004199 Oenanthe sarmentosa Nutrition 0.000 claims description 69
- 235000003828 Sium suave Nutrition 0.000 claims description 69
- 229940117336 parsley extract Drugs 0.000 claims description 46
- 235000013305 food Nutrition 0.000 claims description 21
- 235000015206 pear juice Nutrition 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 4
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 abstract description 4
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 abstract description 4
- 235000008800 isorhamnetin Nutrition 0.000 abstract description 4
- 238000007602 hot air drying Methods 0.000 abstract description 2
- 230000003449 preventive effect Effects 0.000 abstract 1
- 239000000843 powder Substances 0.000 description 14
- 230000000694 effects Effects 0.000 description 13
- 238000000605 extraction Methods 0.000 description 13
- 239000000796 flavoring agent Substances 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 9
- 239000008194 pharmaceutical composition Substances 0.000 description 9
- 230000035622 drinking Effects 0.000 description 8
- 235000013361 beverage Nutrition 0.000 description 7
- 235000013355 food flavoring agent Nutrition 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 201000010041 presbyopia Diseases 0.000 description 6
- 241000218206 Ranunculus Species 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 241000208317 Petroselinum Species 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000013376 functional food Nutrition 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 235000011197 perejil Nutrition 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- -1 sucrose fatty acid ester Chemical class 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 235000012222 talc Nutrition 0.000 description 3
- 229940124597 therapeutic agent Drugs 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000220324 Pyrus Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 235000001465 calcium Nutrition 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 235000019997 soju Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 229940032147 starch Drugs 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 206010001623 Alcoholic hangover Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 235000009852 Cucurbita pepo Nutrition 0.000 description 1
- 240000001980 Cucurbita pepo Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000511338 Haliaeetus leucocephalus Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- 241000320380 Silybum Species 0.000 description 1
- 235000010841 Silybum marianum Nutrition 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 239000003006 anti-agglomeration agent Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 208000024330 bloating Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 210000000692 cap cell Anatomy 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000005095 gastrointestinal system Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229940043353 maltol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 235000015041 whisky Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
- A23L27/12—Natural spices, flavouring agents or condiments; Extracts thereof from fruit, e.g. essential oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/334—Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
Abstract
Description
본 발명은 미나리 추출물을 포함하는 숙취 해소 및 예방용 조성물에 관한 것으로, 상기 미나리 추출물은 이소람네틴 함량이 높고, 숙취를 해소할 뿐만 아니라 음주 시 숙취를 예방하는 효과가 있다.The present invention relates to a composition for relieving and preventing a hangover comprising a water parsley extract, wherein the water parsley extract has a high isoramnetine content, and has an effect of not only relieving a hangover but also preventing a hangover when drinking.
술은 예로부터 인류의 역사와 더불어 널리 이용되어 온 기호식품의 한가지로, 축제나 종교적 의식, 약용, 스트레스 해소 등의 목적으로 많이 이용되고 있다. 그러나 과도한 음주는 알코올성 숙취로 인한 메스꺼움, 구토, 현기증, 갈증, 무기력, 두통, 근육통 등의 증상을 야기시키고, 이는 업무 능률 저하로 인한 사회·경제적 손해를 초래할 뿐 아니라 간, 위, 췌장, 위장계, 뇌, 신경계 등 전신의 장기에 악영향을 미치기도 하며, 정신적으로 황폐화시키고 심하면 공황상태로까지 발전시켜서 각종 사회문제를 야기하기도 한다(박승만과 조종관, 1993; Swift R and Davidson D, 1998).Alcohol is one of the favorite foods that have been widely used along with human history since ancient times, and is widely used for festivals, religious ceremonies, medicinal purposes, and stress relief. However, excessive drinking causes symptoms such as nausea, vomiting, dizziness, thirst, lethargy, headache, and muscle pain due to alcoholic hangover, which not only causes social and economic damage due to decreased work efficiency, but also causes liver, stomach, pancreas, and gastrointestinal system , brain, nervous system, etc., adversely affects the organs of the whole body, mentally devastated and, in severe cases, even develops into a state of panic, causing various social problems (Sung-Man Park and Jo Jung-Kwan, 1993; Swift R and Davidson D, 1998).
이에 예로부터 음주 후 숙취해소를 위해 콩나물, 북어 등을 이용한 식품들이 이용되어 왔으며, 최근에는 음주 전후에 숙취와 간 보호를 위한 많은 기능성 음료 또는 식품들이 많은 각광을 받고 있으며, 이 중에도 숙취해소용 음료가 가장 많은 소비가 이루어지고 있다. 구체적으로, 주된 음주연령층인 30~50대의 직장인들이 소주나 위스키 등 비교적 고알코올을 선호하는 음주층으로 음주 후 다음날 원활한 활동을 위하여 숙취해소용 음료를 선호하고 있으며, 여성과 대학생층 등 젊은 층에서도 그 수요가 점차 늘어나고 있는 추세이다. 그러나 현재 시판되고 있는 제품들은 복부팽만감, 구토 또는 복통 등의 부작용을 유발하는 문제가 있기 때문에 천연물로부터 유래하여 부작용이 적으면서 전반적인 숙취증상을 효과적으로 제거하는 효능이 있는 기능성 음료 또는 약제학적 조성물에 대한 개발이 진행되고 있다.For this reason, foods using bean sprouts and bald eagles have been used to relieve hangovers after drinking. Recently, many functional drinks or foods for hangover and liver protection before and after drinking have been in the spotlight. Among them, hangover relief drinks is the largest consumption. Specifically, office workers in their 30s and 50s, the main drinking age group, prefer relatively high alcohol drinks such as soju or whiskey. Demand is gradually increasing. However, since products currently on the market have a problem of causing side effects such as bloating, vomiting, or abdominal pain, they are derived from natural products and have fewer side effects and are effective in effectively removing overall hangover symptoms. Development of a functional beverage or pharmaceutical composition This is in progress.
미나리(Oenanthe javanica)는 피를 맑게 해주는 대표적인 식품으로 옛날부터 귀하게 여겨 궁중에 진상하던 식품으로서, 진한 정유성분으로 인하여 독특한 향과 맛을 지니기도 하지만, 비타민 A와 C, 칼슘, 철분 등 무기질도 풍부한 대표적인 알칼리성 식품이다. 「동의보감」이나 「본초습유」에 따르면 "미나리는 머리를 맑게 하며, 대장과 소장을 원활하게 하여 신진대사를 촉진시키고, 고열을 내려주고 류머티즘에 유효하며 여러 가지 병증에 유효하다"는 기록이 있으며, 혈압을 내려주는 효능이 인정되어 고혈압 환자들이 즐겨먹는 식품 중 하나이고, 그 밖에 변비해소 및 각종 체내 독성물질을 중화시키거나 제거하는 작용도 있다고 알려져 있다.Water parsley ( Oenanthe javanica ) is a representative food that purifies the blood and has been valued since ancient times and served in the royal court. It has a unique flavor and taste due to its rich essential oil component, but also contains vitamins A and C, calcium, iron, and other minerals. It is an abundant representative alkaline food. According to 「Donguibogam」 or 「Bonchosupyu」, there is a record that "water parsley clears the head, smoothes the large intestine and small intestine, promotes metabolism, lowers high fever, is effective for rheumatism, and is effective for various ailments". , blood pressure lowering effect has been recognized, so it is one of the favorite foods for high blood pressure patients, and it is also known to have the effect of relieving constipation and neutralizing or removing various toxic substances in the body.
본 발명의 하나의 목적은 이소람네틴을 높은 함량으로 포함하는 미나리 추출물을 제조하는 방법을 제공하는 것이다.One object of the present invention is to provide a method for preparing a water parsley extract containing isoramnetine in a high content.
본 발명의 다른 하나의 목적은 상기 제조된 미나리 추출물을 포함하는 숙취 해소 및/또는 예방용 조성물을 제공하는 것이다.Another object of the present invention is to provide a composition for relieving and/or preventing a hangover comprising the prepared water parsley extract.
하나의 양태로서, 본 발명은 이소람네틴을 높은 함량으로 포함하는 미나리 추출물의 제조 방법을 제공한다.In one aspect, the present invention provides a method for producing a water parsley extract comprising isoramnetine in a high content.
구체적으로, 본 발명은 미나리의 가식 부위를 건조하고 분쇄하는 단계, 및 상기 미나리 분쇄물을 75% 에탄올과 이의 20배의 물을 용매로 하여 추출물을 제조하는 단계로 이루어진 이소람네틴을 높은 함량으로 포함하는 미나리 추출물의 제조 방법을 제공한다.Specifically, the present invention provides isoramnetine in a high content, comprising the steps of drying and pulverizing the edible part of water parsley, and preparing an extract using 75% ethanol and 20 times its water as a solvent for the pulverized water parsley. It provides a method for producing a water parsley extract comprising
상기 미나리(Oenanthe javanica)는 미나리과에 속하는 잎줄기채소로서, 한약명으로는 ‘수근(水芹)’ 또는 ‘수영(水英)’이라 한다. 상기 미나리는 우리나라의 전역에서 생산하고 있지만, 나주 노안 지역에서 생산된 미나리인 것이 바람직하다.The water parsley ( Oenanthe javanica ) is a leafy vegetable belonging to the buttercup family. Although the water parsley is produced throughout the country, it is preferable that the water parsley is produced in the Noan area of Naju.
상기 미나리는 플라보노이드의 일종인 이소람네틴을 다량 함유하고 있는 것으로 알려져 있으나, 종래의 미나리 열수 추출물은 이소람네틴의 추출 수율이 낮다는 단점이 있었다. 그러나, 상술한 방법에 의할 경우 이소람네틴을 고함량으로 함유하는 미나리 추출물을 제조할 수 있다.The water parsley is known to contain a large amount of isoramnetin, a kind of flavonoid, but the conventional hot water extract of water parsley has a disadvantage in that the extraction yield of isoramnetin is low. However, according to the method described above, it is possible to prepare a water parsley extract containing isoramnetine in a high content.
여기서, 고함량은 미나리 추출물의 총 중량에 대하여 0.7 내지 0.72 중량%, 바람직하게는 0.7 내지 0.71 중량%, 보다 바람직하게는 0.705 내지 0.71 중량%로 함유한다.Here, the high content is contained in an amount of 0.7 to 0.72% by weight, preferably 0.7 to 0.71% by weight, and more preferably 0.705 to 0.71% by weight, based on the total weight of the water parsley extract.
또한, 고함량은 미나리 열수 추출물에 함유된 이소람네틴의 함량과 대비하여 70배 내지 72배, 바람직하게는 70배 내지 71배, 보다 바람직하게는 70.5배 내지 71배로 존재하는 것을 의미한다.In addition, the high content means that it is present in an amount of 70 to 72 times, preferably 70 to 71 times, more preferably 70.5 to 71 times compared to the content of isoramnetin contained in the water parsley hot water extract.
이하, 본 발명에 따른 이소람네틴을 높은 함량으로 포함하는 미나리 추출물의 제조 방법을 구체적으로 설명한다.Hereinafter, a method for producing a water parsley extract containing isoramnetin in a high content according to the present invention will be described in detail.
먼저, 미나리의 가식 부위를 건조하고 분쇄하는 단계이다.First, it is a step of drying and pulverizing the decorative part of water parsley.
상기 미나리는 상술한 바와 같으며, 상기 미나리의 가식 부위는 미나리의 뿌리를 제외한 잎 및 줄기를 말한다.The water parsley is the same as described above, and the decorative part of the water parsley refers to the leaves and stems except for the root of the water parsley.
상기 건조는 미나리의 수분함량을 20% 이하, 바람직하게는 1 내지 15%, 보다 바람직하게는 1 내지 10%로 유지하는 것으로, 통상의 건조 방법, 예를 들어 열풍건조, 동결건조, 자연건조, 냉풍건조, 진공건조 등의 방법을 사용할 수 있다.The drying is to maintain the water content of water parsley at 20% or less, preferably 1 to 15%, more preferably 1 to 10%, and a conventional drying method, for example, hot air drying, freeze drying, natural drying, Methods such as cold air drying and vacuum drying can be used.
상기 분쇄는 건조된 미나리를 추출이 용이한 크기로 잘게 부수는 과정으로, 통상의 분쇄기를 이용하여 크기(가로, 세로, 및 두께)가 1mm 이하, 바람직하게는 0.5mm 이하, 보다 바람직하게는 0.1mm 이하로 세절하는 과정이다.The pulverization is a process of crushing dried water parsley into a size that is easy to extract, and the size (width, length, and thickness) is 1 mm or less, preferably 0.5 mm or less, more preferably 0.1 using a conventional grinder. This is the process of slicing down to mm.
다음으로, 상기 미나리 분쇄물을 75% 에탄올과 이의 20배의 물을 용매로 하여 추출물을 제조하는 단계이다.Next, using the pulverized water parsley with 75% ethanol and 20 times its water as a solvent, an extract is prepared.
하나의 구체적 예로서, 상기 단계에서 제조된 미나리 분쇄물을 75% 에탄올과 상기 에탄올 부피의 20배의 물을 용매로 하여 추출하는 경우 이소람네틴 함량이 가장 우수하였다.As a specific example, when the pulverized water parsley prepared in the above step was extracted using 75% ethanol and 20 times the volume of the ethanol as a solvent, the content of isoramnetine was the best.
또한, 상기 용매를 이용하여 추출할 때 55 내지 65℃, 바람직하게는 58 내지 62℃, 보다 바람직하게는 60℃에서 22 내지 26시간, 바람직하게는 23 내지 25시간, 가장 바람직하게는 24시간 동안 추출하는 경우 다른 온도 및 시간 조건에 비하여 이소람네틴 함량이 가장 우수하였다.In addition, when extracting using the solvent, 55 to 65 ℃, preferably 58 to 62 ℃, more preferably at 60 ℃ 22 to 26 hours, preferably 23 to 25 hours, most preferably for 24 hours In the case of extraction, the content of isoramnetine was the best compared to other temperature and time conditions.
상기한 방법에 의하여 제조된 미나리 추출물은 이소람네틴 함량이 미나리 추출물의 총 중량을 기준으로 0.7 내지 0.72 중량%, 바람직하게는 0.7 내지 0.71 중량%, 보다 바람직하게는 0.705 내지 0.71 중량%로서 고함량 함유한다.The water parsley extract prepared by the above method has an isoramnetin content of 0.7 to 0.72 wt%, preferably 0.7 to 0.71 wt%, more preferably 0.705 to 0.71 wt%, based on the total weight of the parsley extract. contains
또한, 상기 방법에 의하여 제조된 미나리 추출물은 미나리 열수 추출물에 비하여 70배 내지 72배, 바람직하게는 70배 내지 71배, 보다 바람직하게는 70.5배 내지 71배 높은 이소람네틴 함량을 나타낸다.In addition, the water parsley extract prepared by the above method exhibits an isoramnetine content that is 70 to 72 times, preferably 70 to 71 times, more preferably 70.5 to 71 times higher than that of the water parsley hot water extract.
다른 하나의 양태로서, 본 발명은 미나리 추출물을 포함하는 숙취 해소 및 예방용 조성물을 제공한다.In another aspect, the present invention provides a composition for relieving and preventing a hangover comprising a water parsley extract.
본 발명에 있어서, 상기 미나리 추출물은 상술한 방법에 의하여 제조된 추출물이다. 상기 방법에 의하여 제조된 미나리 추출물은 단시간에 제조할 수 있을 뿐만 아니라 다른 추출 방법과 비교하여 높은 이소람네틴을 함유하고 있으며, 숙취의 해소 및 예방에 우수한 효과가 있다.In the present invention, the water parsley extract is an extract prepared by the above-described method. The water parsley extract prepared by the above method not only can be prepared in a short time, but also contains high isoramnetine compared to other extraction methods, and has an excellent effect in relieving and preventing hangover.
상기 미나리 추출물은 이소람네틴을 미나리 추출물의 총 중량을 기준으로 0.7 내지 0.72 중량%, 바람직하게는 0.7 내지 0.71 중량%, 보다 바람직하게는 0.705 내지 0.71 중량% 함량으로 고함량 함유한다.The water parsley extract contains a high content of isoramnetin in an amount of 0.7 to 0.72 wt%, preferably 0.7 to 0.71 wt%, more preferably 0.705 to 0.71 wt%, based on the total weight of the parsley extract.
본 발명에 있어서, 상기 숙취 해소 및 예방용 조성물은 미나리 추출물을 조성물의 총 중량에 대하여 1 내지 20 중량%, 바람직하게는 5 내지 20 중량%, 보다 바람직하게는 5 내지 18 중량%, 보다 더 바람직하게는 5 내지 15 중량%로 함유한다. 미나리 추출물의 함량이 1 중량% 미만인 경우 목적으로 하는 숙취 해소 및 예방 효과를 얻을 수 없으며, 20 중량% 초과인 경우 함량 증가에 따른 숙취 해소 및 예방 효과의 증가가 미미하다.In the present invention, the composition for relieving and preventing hangover contains water parsley extract in an amount of 1 to 20% by weight, preferably 5 to 20% by weight, more preferably 5 to 18% by weight, even more preferably, based on the total weight of the composition. Preferably, it contains 5 to 15% by weight. When the content of water parsley extract is less than 1% by weight, the desired hangover relief and prevention effect cannot be obtained, and when it exceeds 20% by weight, the increase in hangover relief and prevention effect according to the increase in the content is insignificant.
하나의 구체적 예로서, 본 발명에 따른 조성물을 술을 마신 10명의 남여 실험군이 음용하였을 때 물 음용군(대조군), 시판되는 제품 음용군(비교군 1), 미나리의 열수 추출물(비교군 2)에 비하여 음용시의 맛과 향이 우수하였고, 숙취 해소 효과도 매우 우수하였다.As a specific example, when 10 male and female experimental groups who drank the composition according to the present invention drank, a water drinking group (control group), a commercially available product drinking group (comparative group 1), and hot water extract of water parsley (comparative group 2) The taste and flavor when drinking were superior, and the effect of relieving hangover was also very good.
따라서, 본 발명의 상기 조성물은 숙취 해소 및 예방 효과가 매우 우수하다.Therefore, the composition of the present invention is very excellent in relieving hangover and preventing effect.
하나의 구체적 양태로서, 본 발명의 숙취 해소 및 예방용 조성물은 미나리 추출물 이외에 배즙을 추가로 더 포함할 수 있다.As a specific embodiment, the composition for relieving and preventing hangovers of the present invention may further include pear juice in addition to the water parsley extract.
상기 배즙은 통상의 방법에 의하여 제조된 것일 수 있으나, 구체적으로 배를 깨끗이 세척하고 꼭지를 제거한 후 적절한 크기로 절단한 다음 착즙기로 착즙하여 제조할 수 있다.The pear juice may be prepared by a conventional method, but specifically, it may be prepared by washing the pear thoroughly, removing the stem, cutting it to an appropriate size, and then juicing it with a juicer.
상기 배즙은 미나리 추출물의 함량과 동등한 양으로 첨가하는 것이 바람직하다.The pear juice is preferably added in an amount equal to the content of water parsley extract.
하나의 구체적 예로서, 본 발명에 따른 상기 조성물에 배즙을 첨가한 조성물을 술을 마신 10명의 남여 실험군이 음용하였을 때 미나리 추출물만을 포함하는 조성물에 비하여 음용시의 맛과 향이 보다 더 우수하였고, 숙취 해소 효과도 보다 더 우수한 것으로 조사되었다.As a specific example, when 10 male and female experimental groups who drank the composition in which pear juice was added to the composition according to the present invention drank, the taste and flavor were superior to that of the composition containing only water parsley extract, and the taste and aroma were superior to those of the composition containing water parsley extract. The resolving effect was also found to be more excellent.
본 발명의 조성물은 사용 목적에 따라 약학적 조성물, 식품 조성물, 식품 또는 건강기능 식품일 수 있다.The composition of the present invention may be a pharmaceutical composition, food composition, food or health functional food depending on the intended use.
하나의 구체적 양태로서, 본 발명은 이소람네틴을 고함량으로 함유하는 미나리 추출물, 또는 상기 미나리 추출물과 배즙을 유효성분으로 포함하는 숙취해소 및 예방용 약학 조성물을 제공한다As a specific aspect, the present invention provides a water parsley extract containing a high content of isoramnetin, or a pharmaceutical composition for relieving and preventing hangovers comprising the water parsley extract and pear juice as active ingredients
본 발명의 약학 조성물은 각각의 사용 목적에 맞게 통상의 방법에 따라 산제, 과립제, 정제, 캡슐제, 현탁제, 에멀젼, 시럽, 에어로졸 등의 경구 제형, 멸균 주사용액의 주사제 등 다양한 형태로 제형화하여 사용할 수 있으며, 경구 투여하거나 정맥 내, 복강 내, 피하, 직장, 국소 투여 등을 포함한 다양한 경로를 통해 투여될 수 있다.The pharmaceutical composition of the present invention is formulated in various forms such as oral formulations such as powders, granules, tablets, capsules, suspensions, emulsions, syrups and aerosols, and injections of sterile injection solutions according to conventional methods for each purpose of use. and can be administered orally, or administered through various routes including intravenous, intraperitoneal, subcutaneous, rectal, topical administration, and the like.
이러한 약학 조성물에 포함될 수 있는 약학적으로 허용가능한 담체, 부형제 또는 희석제의 예로는 락토오스, 덱스트로스, 수크로스, 솔비톨, 만니톨, 자일리톨, 에리쓰리톨, 말티톨, 전분, 아카시아 고무, 알지네이트, 젤라틴, 칼슘 포스페이트, 칼슘 실리케이트, 셀룰로스, 메틸 셀룰로스, 비정질 셀룰로스, 결정셀룰로오스, 카르복시메틸셀룰로오스, 카르복시메틸셀룰로오스 칼슘, 카르복시메틸셀룰로오스 나트륨, 전분글리코산 나트륨, 싸이클로덱스트린, 저치환도히드록시프로필셀룰로오스, 히드록시에틸셀룰로오스, 히드록시프로필셀룰로오스, 잔탄검, 구어검, 한천, 구연산, 구연산나트륨, 알긴산나트륨, 폴리비닐 피롤리돈, 물, 메틸하이드록시벤조에이트, 프로필하이드록시벤조에이트, 탈크, 스테아린산마그네슘, 자당지방산에스테르, 패각칼슘, 마그네슘 스테아레이트, 탈크 및 광물유 등을 들 수 있다.Examples of pharmaceutically acceptable carriers, excipients or diluents that may be included in such pharmaceutical compositions include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, gum acacia, alginate, gelatin, calcium Phosphate, calcium silicate, cellulose, methyl cellulose, amorphous cellulose, crystalline cellulose, carboxymethyl cellulose, carboxymethyl cellulose calcium, carboxymethyl cellulose sodium, sodium starch glycolate, cyclodextrin, low-substituted hydroxypropyl cellulose, hydroxyethyl cellulose , hydroxypropyl cellulose, xanthan gum, gourd gum, agar, citric acid, sodium citrate, sodium alginate, polyvinyl pyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate, sucrose fatty acid ester , shell calcium, magnesium stearate, talc and mineral oil.
본 발명의 약학 조성물은 추가적인 보조제로 비타민 B군, 비타민 C, 비타민 E, 베타카로틴, Ca, Mg, Zn, 레시틴, 알라닌, 타우린, 말톨, 과당, 올리고당, 영지, 글루메이트, 키토산, 아스파라긴산, 동충하초, 밀크시슬 등을 더 포함할 수 있다.The pharmaceutical composition of the present invention is an additional auxiliary agent, vitamin B group, vitamin C, vitamin E, beta-carotene, Ca, Mg, Zn, lecithin, alanine, taurine, maltol, fructose, oligosaccharide, reishi, glutate, chitosan, aspartic acid, Cordyceps , and may further include milk thistle.
본 발명의 약학 조성물은 충전제, 항응집제, 윤활제, 습윤제, 향료, 유화제, 방부제 등을 추가로 포함할 수 있다. 경구 투여를 위한 고형 제제에는 정제, 환제, 산제, 과립제, 캡슐제 등이 포함되며, 이러한 고형 제제는 상기 조성물에 적어도 하나 이상의 부형제, 예를 들면 전분, 유당, 탄산칼슘, 수크로스, 락토오스, 젤라틴 등을 혼합하여 제형화한다. 또한, 단순한 부형제 이외에 마그네슘 스테아레이트, 탈크와 같은 윤활제가 사용될 수 있다. 경구용 액상 제제로는 현탁제, 내용액제, 유제, 시럽제 등이 예시될 수 있으며, 흔히 사용되는 단순 희석제인 물, 액체 파라핀 이외에 여러 가지 부형제, 예를 들면 습윤제, 감미제, 방향제, 보존제 등이 포함될 수 있다.The pharmaceutical composition of the present invention may further include a filler, an anti-agglomeration agent, a lubricant, a wetting agent, a flavoring agent, an emulsifier, a preservative, and the like. Solid preparations for oral administration include tablets, pills, powders, granules, capsules, etc., and such solid preparations include at least one excipient in the composition, for example, starch, lactose, calcium carbonate, sucrose, lactose, gelatin. It is formulated by mixing, etc. In addition to simple excipients, lubricants such as magnesium stearate and talc may be used. Liquid formulations for oral use may include suspensions, solutions, emulsions, syrups, etc., and various excipients, such as wetting agents, sweeteners, fragrances, preservatives, etc., in addition to water and liquid paraffin, which are commonly used simple diluents, may be included. can
본 발명의 조성물이 약학 조성물인 경우 약제학적으로 유효한 양으로 투여한다. 본 발명에서, "약제학적으로 유효한 양"은 의학적 치료에 적용 가능한 합리적인 수혜/위험 비율로 질환을 치료하기에 충분한 양을 의미하며, 유효 용량 수준은 환자의 질환의 종류, 중증도, 약물의 활성, 약물에 대한 민감도, 투여 시간, 투여 경로 및 배출 비율, 치료 기간, 동시 사용되는 약물을 포함한 요소 및 기타 의학 분야에 잘 알려진 요소에 따라 결정될 수 있다. 본 발명의 조성물은 개별 치료제로 투여하거나 다른 치료제와 병용하여 투여될 수 있고, 종래의 치료제와 순차적으로 또는 동시에 투여될 수 있으며, 단일 또는 다중 투여될 수 있다. 상기한 요소들을 모두 고려하여 부작용 없이 최소한의 양으로 최대 효과를 얻을 수 있는 양을 투여하는 것이 중요하며, 이는 당업자에 의해 용이하게 결정될 수 있다. 구체적으로, 본 발명의 조성물에서 유효성분의 유효량은 환자의 나이, 성별, 체중에 따라 달라질 수 있는데, 10 내지 20,000 mg 바람직하게는 100 내지 5,000mg을 투여할 수 있다. 그러나, 투여 경로, 질병의 중증도, 성별, 체중, 연령 등에 따라서 증감될 수 있으므로 상기 투여량이 어떠한 방법으로도 본 발명의 범위를 한정하는 것은 아니다When the composition of the present invention is a pharmaceutical composition, it is administered in a pharmaceutically effective amount. In the present invention, "pharmaceutically effective amount" means an amount sufficient to treat a disease with a reasonable benefit/risk ratio applicable to medical treatment, and the effective dose level is determined by the type, severity, activity of the drug, and the type of disease in the patient; Sensitivity to the drug, time of administration, route of administration and excretion rate, duration of treatment, factors including concomitant drugs and other factors well known in the medical field. The composition of the present invention may be administered as an individual therapeutic agent or in combination with other therapeutic agents, may be administered sequentially or simultaneously with conventional therapeutic agents, and may be administered singly or multiple times. In consideration of all of the above factors, it is important to administer an amount that can obtain the maximum effect with a minimum amount without side effects, which can be easily determined by those skilled in the art. Specifically, the effective amount of the active ingredient in the composition of the present invention may vary depending on the age, sex, and weight of the patient, 10 to 20,000 mg, preferably 100 to 5,000 mg may be administered. However, the dosage is not intended to limit the scope of the present invention in any way, as it may increase or decrease depending on the route of administration, disease severity, sex, weight, age, etc.
다른 하나의 구체적 양태로서, 본 발명은 이소람네틴을 고함량으로 함유하는 미나리 추출물, 또는 상기 미나리 추출물과 배즙을 유효성분으로 포함하는 숙취해소 및 예방용 식품을 제공한다As another specific aspect, the present invention provides a water parsley extract containing a high content of isoramnetin, or a food for relieving and preventing hangovers comprising the water parsley extract and pear juice as active ingredients
본 발명의 미나리 추출물 또는 미나리 추출물과 배즙을 식품에 그대로 첨가하거나 다른 식품 또는 식품 성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다.The water parsley extract or water parsley extract and pear juice of the present invention may be added to food as it is, or used together with other foods or food ingredients, and may be appropriately used according to a conventional method.
상기 추출물을 첨가할 수 있는 식품으로는, 예를 들어, 각종 식품류, 음료, 껌, 차, 캔디, 비타민 복합제, 건강 기능성 식품류, 분말, 과립, 정제, 캡슐, 젤리 또는 음료 등이 있으며, 이에 특별한 제한이 없다.Foods to which the extract can be added include, for example, various foods, beverages, gum, tea, candy, vitamin complexes, health functional foods, powders, granules, tablets, capsules, jellies, or beverages, and there are special no limits.
바람직하게는 숙취 해소를 목적으로 식품 또는 음료에 첨가될 수 있다. 이때, 식품 또는 음료 중의 상기 미나리 추출물 또는 미나리 추출물과 배즙의 양은 전체 식품 중량의 0.01 내지 15 중량%로 가할 수 있으며, 음료 조성물은 100 mL를 기준으로 0.01 내지 20 g, 바람직하게는 0.1 내지 5 g의 비율로 가할 수 있다. 본 발명의 식품은 지시된 비율로 필수 성분으로서 상기 추출물을 함유하는 외에는 다른 성분에는 특별한 제한이 없으며 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 첨가제로서 함유할 수 있다. 위 천연 탄수화물은 포도당, 과당, 말토스, 슈크로스, 덱스트린, 시클로덱스트린과 같은 사카라이드류가 있으며, 자일리톨, 소르비톨, 에리트리톨 등의 당알코올이 있다. 상기 향미제는 천연 향미제(타우마틴, 스테비아 추출물(예를 들어 레바우디오시드 A, 글리시르히진등) 및 합성 향미제(사카린, 아스파르탐 등)를 사용할 수 있다. 또한 본 발명의 식품은 추가로 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제, 펙트산 및 그의 염, 알긴산, 구연산, 구연산 나트륨 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산 음료에 사용되는 탄산화제 등을 함유할 수 있다. 이러한 첨가제는 본 발명의 미나리 추출물 또는 미나리 추출물과 배즙의 혼합물 1 중량부 당 0.01 내지 약 50 중량부의 범위에서 선택되는 것이 일반적이다.Preferably, it may be added to food or beverages for the purpose of relieving a hangover. At this time, the amount of the water parsley extract or water parsley extract and pear juice in the food or beverage may be added in an amount of 0.01 to 15% by weight of the total food weight, and the beverage composition is 0.01 to 20 g, preferably 0.1 to 5 g, based on 100 mL can be added in a proportion of The food of the present invention is not particularly limited in other ingredients except for containing the extract as an essential ingredient in the indicated ratio, and may contain various flavoring agents or natural carbohydrates as additives, like conventional beverages. The above natural carbohydrates include saccharides such as glucose, fructose, maltose, sucrose, dextrin, and cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol. As the flavoring agent, natural flavoring agents (taumartin, stevia extract (eg, rebaudioside A, glycyrrhizin, etc.) and synthetic flavoring agents (saccharin, aspartame, etc.) may be used. Also, the food of the present invention In addition to various nutrients, vitamins, minerals (electrolytes), flavoring agents such as synthetic and natural flavoring agents, coloring and thickening agents, pectic acid and its salts, alginic acid, citric acid, sodium citrate and salts thereof, organic acids, protective It may contain a sexual colloid thickener, pH adjuster, stabilizer, preservative, glycerin, alcohol, carbonation agent used in carbonated drinks, etc. These additives are 0.01 per 1 part by weight of the water parsley extract of the present invention or the mixture of water parsley extract and pear juice to about 50 parts by weight.
본 발명에 따른 미나리 추출물의 제조 방법은 이소람네틴을 최적의 수율로서 고함량으로 추출할 수 있고, 이를 포함하는 미나리 추출물은 숙취 해소 및 예방 효과가 통상의 미나리 추출물에 비하여 현저히 우수한 효과가 있으므로, 숙취 해소 및 예방용 약학적 조성물 및 식품, 기능성 식품으로서 유용하게 사용할 수 있다.The method for producing a water parsley extract according to the present invention can extract isoramnetin in a high content with an optimal yield, and the water parsley extract containing it has a remarkably superior effect in relieving and preventing a hangover compared to a common water parsley extract, It can be usefully used as a pharmaceutical composition for hangover relief and prevention, and as a food or functional food.
이하, 본 발명의 이해를 돕기 위하여 실시예 등을 들어 상세하게 설명하기로 한다. 그러나, 본 발명에 따른 실시예들은 여러 가지 다른 형태로 변형될 수 있으며, 본 발명의 범위가 하기 실시예들에 한정되는 것으로 해석되어서는 안 된다. 본 발명의 실시예들은 당업계에서 평균적인 지식을 가진 자에게 본 발명을 보다 완전하게 설명하기 위해 제공되는 것이다.Hereinafter, examples and the like will be described in detail to help the understanding of the present invention. However, the embodiments according to the present invention may be modified in various other forms, and the scope of the present invention should not be construed as being limited to the following examples. The embodiments of the present invention are provided to more completely explain the present invention to those of ordinary skill in the art.
재료 준비 및 실험 방법Material preparation and experimental methods
나주시장에서 나주 노안산 미나리를 구매하고 이를 60℃에서 4일 동안 열풍건조한 후 분쇄기(SHINIL, SMX-9400MD)로 1분 동안 분쇄하여 분말화한 후(이후‘노안미나리 열풍건조 분말’이라 함) 이하의 실험을 수행하였다.Purchase water parsley from Naju Noan at Naju Market, dry it with hot air at 60°C for 4 days, and then pulverize it with a grinder (SHINIL, SMX-9400MD) for 1 minute to make powder (hereinafter referred to as 'hot air dried powder for Noan water parsley') The following experiments were performed.
미나리 추출물의 지표 성분으로 이소람네틴(isorhamnetin)을 선정하고 이의 함량을 다음의 방법으로 측정하였다. 먼저 이소람네틴 10 mg 취하여 100 ml 부피플라스크에 넣고 5% 황산용액(H2O/MeOH/H2SO4 = 45/50/5(v/v))을 이용하여 완전히 녹인 다음, 표선까지 채운 후 절반 씩 단계 희석하여 서로 다른 농도(1.56, 3.125, 6.25, 12.5, 25 ug/ml)를 준비하였다 상기 준비된 노안미나리 열풍건조물 0.3g을 취하여 5% 황산용액(H2O/MeOH/H2SO4 = 45/50/5(v/v))을 첨가한 후 용해시킨 다음, 30분간 90℃에서 반응하고 식힌 후, 동량의 에틸아세테이트를 넣고 3회 추출 하였으며, 회수한 상징액을 건조하고 MeOH 1mL에 용해시킨 후 0.45μM 시린지 필터(syringe filter)로 여과하고, 이를 시험용액으로 하여 HPLC 분석을 하였다.Isorhamnetin was selected as an indicator component of water parsley extract, and its content was measured by the following method. First, take 10 mg of isoramnetine, put it in a 100 ml volumetric flask, dissolve it completely using 5% sulfuric acid solution (H2O/MeOH/H2SO4 = 45/50/5(v/v)), fill it up to the mark, and then dilute it in half. with different concentrations (1.56, 3.125, 6.25, 12.5 , 25 ug / ml) was prepared by taking the hot-air dried material prepared presbyopia buttercup 0.3g 5% sulfuric acid solution (H 2 O / MeOH / H 2 SO 4 = 45/50 /5 (v/v)) was added and dissolved, and then reacted at 90° C. for 30 minutes and cooled. Then, the same amount of ethyl acetate was added and extracted three times. The recovered supernatant was dried and dissolved in 1 mL of MeOH, followed by 0.45. Filtration was performed with a μM syringe filter, and HPLC analysis was performed using this as a test solution.
하기 표 1은 이소람네틴 HPLC 분석 조건이다.Table 1 below is isoramnetine HPLC analysis conditions.
B : 100% Acetonitrile
C : 100% Distilled Water0.8 mL/min
B: 100% Acetonitrile
C: 100% Distilled Water
실시예 1: 추출 용매에 따른 이소람네틴 함량 측정Example 1: Measurement of isoramnetine content according to extraction solvent
상기 제조된 노안미나라 열풍건조 분말을 추출 용매(물 또는 에탄올)에 따른 이소람네틴 함량을 측정하였다. 구체적으로, 노안미나리 열풍건조물을 물 100%, 에탄올 농도(25%, 50%, 75%, 및 100%)별로 실온에서 24시간 동안 침지한 후 추출물을 제조하고 이의 이소람네틴 함량을 상기 방법으로 측정하였다, 그 결과를 하기 표 2에 나타내었으며, 75% 에탄올 농도에서 이소람네틴 함량이 가장 높았다.The content of isoramnetin according to the extraction solvent (water or ethanol) of the prepared Noanminara hot air dried powder was measured. Specifically, after immersing the dried water parsley hot air dried product by 100% water and ethanol concentration (25%, 50%, 75%, and 100%) at room temperature for 24 hours, an extract was prepared and its isoramnetine content was measured by the above method. was measured, and the results are shown in Table 2 below, and the isoramnetine content was the highest at 75% ethanol concentration.
열풍건조 분말presbyopia buttercup
hot air dried powder
실시예 2: 가수량에 따른 이소람네틴 함량 측정Example 2: Measurement of isoramnetine content according to the amount of water
상기 실시예 1에 더하여 75% 에탄올에 가수량별 이소람네틴 함량을 측정하였다. 구체적으로, 상기 제조된 노안미나리 열풍건조 분말을 75% 에탄올 함량의 10배, 20배, 30배, 및 40배 함량으로 가수한 후 실온에서 24시간 동안 침지하여 추출물을 제조하고 이의 이소람네틴 함량을 측정하였다. 이의 결과를 하기 표 3에 나타내었고, 20배 가수하였을 때 이소람네틴 함량이 가장 높았다.In addition to Example 1, isoramnetine content was measured for each amount of water in 75% ethanol. Specifically, the prepared Noan parsley hot air dried powder was hydrolyzed at an amount of 10 times, 20 times, 30 times, and 40 times the content of 75% ethanol, and then immersed at room temperature for 24 hours to prepare an extract, and its isoramnetine content was measured. The results are shown in Table 3 below, and the content of isoramnetine was the highest when it was hydrolyzed 20 times.
열풍건조 분말presbyopia buttercup
hot air dried powder
실시예 3: 추출 시간에 따른 이소람네틴 함량 측정Example 3: Measurement of isoramnetine content according to extraction time
상기 실시예 1 및 2에 더하여 추출 시간별 이소람네틴 함량을 측정하였다. 구체적으로, 상기 제조된 노안미나리 열풍건조 분말을 75% 에탄올 및 상기 에탄올 함량의 20배를 가수한 용매를 실온에서 6시간, 12시간, 24시간, 및 48시간 침지하여 추출물을 제조하고 이의 이소람네틴 함량을 측정하였다. 이의 결과를 하기 표 4에 나타내었고, 24시간동안 추출하였을 때 이소람네틴 함량이 가장 높았다.In addition to Examples 1 and 2, the content of isoramnetine for each extraction time was measured. Specifically, the prepared Noan parsley hot air dried powder was immersed in 75% ethanol and a solvent obtained by hydrolysis of 20 times the ethanol content at room temperature for 6 hours, 12 hours, 24 hours, and 48 hours to prepare an extract, and its extract The netin content was measured. The results are shown in Table 4 below, and the isoramnetine content was the highest when extracted for 24 hours.
열풍건조 분말presbyopia buttercup
hot air dried powder
실시예 4: 추출 온도에 따른 이소람네틴 함량 측정Example 4: Measurement of isoramnetine content according to extraction temperature
상기 실시예 1 내지 3에 더하여 추출 온도별 이소람네틴 함량을 측정하였다. 구체적으로, 상기 제조된 노안미나리 열풍건조 분말을 75% 에탄올 및 상기 에탄올 함량의 20배를 가수한 용매를 0℃, 실온, 40℃, 60℃, 및 80℃에서 24시간, 침지하여 추출물을 제조하고 이의 이소람네틴 함량을 측정하였다. 이의 결과를 하기 표 5에 나타내었고, 60℃에서 추출하였을 때 이소람네틴 함량이 가장 높았다.In addition to Examples 1 to 3, the content of isoramnetine for each extraction temperature was measured. Specifically, the prepared Noan parsley hot air dried powder was immersed in 75% ethanol and a solvent obtained by adding 20 times the ethanol content at 0 ° C., room temperature, 40 ° C., 60 ° C., and 80 ° C. for 24 hours to prepare an extract and its isoramnetine content was measured. The results are shown in Table 5 below, and the isoramnetine content was the highest when extracted at 60°C.
열풍건조 분말presbyopia buttercup
hot air dried powder
제조예 1:Preparation Example 1:
상기 실시예 1 내지 4에 따라 최적의 방법으로 추출한 노안미나리 추출물, 즉 노안미나리 열풍건조 분말을 75% 에탄올 및 상기 에탄올 함량의 20배를 가수한 용매를 60℃에서 24시간 동안 침지하여 추출한 추출물을 동결건조하였다. 상기 동결건조물 1g을 물 10ml에 희석하여 노안미나리 숙취해소 음료를 제조하였다.The Noan water parsley extract extracted by the optimal method according to Examples 1 to 4, that is, the Noan water parsley hot-air dried powder was immersed in 75% ethanol and a solvent obtained by adding 20 times the ethanol content at 60° C. for 24 hours. Freeze-dried. 1 g of the freeze-dried product was diluted in 10 ml of water to prepare a hangover relieving drink for presbyopia.
제조예 2:Preparation Example 2:
상기 제조예 1에서 제조한 노안미나리 숙취해소 음료에 나주에서 생산한 배를 깨끗이 세척하고 꼭지를 제거한 후 적절한 크기로 절단한 후 착즙기로 착즙한 배즙 1g을 혼합하였다.1 g of pear juice juiced with a juicer was mixed with the Noan water parsley hangover relieving drink prepared in Preparation Example 1 after cleaning the pears produced in Naju, removing the stem, and cutting them to an appropriate size.
제조예 3:Preparation Example 3:
상기 제조예 1과 동일한 방법이나 75% 에탄올 및 20배 가수 용매 대신에 동일 양의 100% 물만을 용매로 하여 추출한 추출물을 사용하였다.In the same manner as in Preparation Example 1, an extract extracted using only the same amount of 100% water as a solvent instead of 75% ethanol and 20-fold hydrolysis solvent was used.
실시예 5: 숙취해소 효능 확인Example 5: Confirmation of hangover relieving efficacy
실험군은 10명(남 7, 여 3, 20∼30세)으로 구성하여 각 주별로 하기 대조군, 비교군, 및 실험군 1 및 2를 음용하도록 하였다. 1주차는 물(대조군), 2주차는 기존의 숙취 해소음료(헛개컨디션, CJ사)(비교군 1), 3주차는 상기 제조예 1의 숙취해소음료(실험군 1), 4주차는 상기 제조예 2의 숙취해소음료(실험군 2), 및 5주차는 상기 제조예 3의 숙취해소음료(비교군 2)를 음용하도록 하고 30분 후부터 19% 보해 참이슬 소주를 50ml씩 5분 간격으로 총 5회 음용하도록 하였다. 술을 마신 후 정수로 입을 헹군 다음, 0분, 60분 120분 후에 호흡 중 알코올 농도 측정기(ALCOFIND DA-5000, (주)디에이텍)로 호흡 중 알코올 농도를 측정하였다. 또한, 상기 음료 섭취시의 맛과 향에 대한 전체 기호도를 관능평가하였는데 대조군을 100으로 정하고 상대평가하였다. 그 결과를 하기 표 6 및 7에 나타내었다.The experimental group consisted of 10 people (7 males, 3 females, 20-30 years old), and the following control groups, comparison groups, and experimental groups 1 and 2 were drank for each week. 1st week is water (control group), 2nd week is the conventional hangover relieving drink (Hutgae Condition, CJ) (Comparative group 1), 3rd week is the hangover relieving drink of Preparation Example 1 (experimental group 1), 4th week is the above manufacturing The hangover relieving drink of Example 2 (experimental group 2), and the 5th week, drink the hangover relieving drink of Preparation Example 3 (comparative group 2), and after 30 minutes, take 19% Bohae Chamisul Soju 50ml each 5 minutes a total of 5 times made to drink. After drinking, rinse your mouth with purified water, and then measure the alcohol concentration during breathing with a breath alcohol concentration meter (ALCOFIND DA-5000, DA Tech) after 0 minutes, 60 minutes and 120 minutes. In addition, sensory evaluation was performed on the overall taste and aroma at the time of ingestion of the beverage. The control group was set as 100 and relative evaluation was performed. The results are shown in Tables 6 and 7 below.
2experimental group
2
1control group
One
2control group
2
상기 표 6 및 7에서 볼 수 있는 바와 같이, 관능평가 및 숙취해소 결과는 시험군 2 > 시험군 1> 비교예 2 > 비교예 1의 순으로 나타나서, 본 발명에 따른 제조된 노안미나리 음료 및 상기 음료에 배즙을 첨가한 것이 관능이 우수하고 숙취 해소에 도움이 되는 것임을 확인할 수 있었다.As can be seen in Tables 6 and 7, the sensory evaluation and hangover relieving results are shown in the order of Test Group 2 > Test Group 1 > Comparative Example 2 > Comparative Example 1, and It was confirmed that the addition of pear juice to the drink has excellent sensory properties and is helpful in relieving hangovers.
Claims (5)
After drying the edible part of the water parsley by hot air, it is extracted with 75% ethanol and 20 times its water as a solvent at 55 to 65 ° C. for 22 to 26 hours. How to.
The water parsley extract according to claim 1, wherein the parsley extract containing isoramnetine in a high content contains 0.7 to 0.72 wt% of isoramnetine based on the total weight of the parsley extract, It contains isoramnetine in a high content A method for producing a water parsley extract.
The method according to claim 1, wherein the water parsley extract containing isoramnetin in a high content contains isoramnetine in an amount 70 to 72 times higher than the content of isoramnetin contained in the water parsley hot water extract. A method for producing a water parsley extract containing isoramnetin in a high content.
A food composition for relieving or preventing a hangover comprising the water parsley extract prepared by the method of any one of claims 1 to 3 as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200065336A KR20210147707A (en) | 2020-05-29 | 2020-05-29 | Composition for relieving and preventing hangover comprising Oenanthe javanica extracts |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200065336A KR20210147707A (en) | 2020-05-29 | 2020-05-29 | Composition for relieving and preventing hangover comprising Oenanthe javanica extracts |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20210147707A true KR20210147707A (en) | 2021-12-07 |
Family
ID=78868513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200065336A KR20210147707A (en) | 2020-05-29 | 2020-05-29 | Composition for relieving and preventing hangover comprising Oenanthe javanica extracts |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20210147707A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114343088A (en) * | 2021-12-27 | 2022-04-15 | 北京康比特体育科技股份有限公司 | Lotus leaf-cassia tora xylose excretion promoting compound beverage and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101280421B1 (en) | 2010-09-08 | 2013-07-01 | 재단법인 전라남도생물산업진흥재단 | Composition for treatment or prevention of learning or memory malfunctions comprising minari extract as a effective component and preparation method thereof |
KR101402322B1 (en) | 2012-12-06 | 2014-06-02 | 대구가톨릭대학교산학협력단 | Method for producing mixed beverage for relieving hangover with increased alcohol degradation activity comprising hot water extract of dropwort and maesaengi |
KR102039912B1 (en) | 2018-11-05 | 2019-12-05 | 주식회사 아리바이오 | Extract of Water Dropwort with organic germanium |
-
2020
- 2020-05-29 KR KR1020200065336A patent/KR20210147707A/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101280421B1 (en) | 2010-09-08 | 2013-07-01 | 재단법인 전라남도생물산업진흥재단 | Composition for treatment or prevention of learning or memory malfunctions comprising minari extract as a effective component and preparation method thereof |
KR101402322B1 (en) | 2012-12-06 | 2014-06-02 | 대구가톨릭대학교산학협력단 | Method for producing mixed beverage for relieving hangover with increased alcohol degradation activity comprising hot water extract of dropwort and maesaengi |
KR102039912B1 (en) | 2018-11-05 | 2019-12-05 | 주식회사 아리바이오 | Extract of Water Dropwort with organic germanium |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114343088A (en) * | 2021-12-27 | 2022-04-15 | 北京康比特体育科技股份有限公司 | Lotus leaf-cassia tora xylose excretion promoting compound beverage and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101288053B1 (en) | Composition for Prevention or Treatment of inner ear damage Comprising an extract of Piper longum L. | |
US10111451B2 (en) | Food, beverage or pharmaceutical composition containing fermented eastern prickly pear and a preparation method therefor | |
KR101874462B1 (en) | Composition for preventing, ameliorating or treating atopic dermatitis comprising Schisandra chinensis leaf extract as effective component | |
KR20110115862A (en) | Composition for reliving and preventing hangover and beverage comprising composition | |
CN113349381A (en) | Food composition capable of relieving depression and preparation method thereof | |
KR102169920B1 (en) | A composition comprising extract of Schisandra chinensis, pear and Platycodon grandiflorum for preventing or treating respiratory inflammatory diseases | |
KR100771525B1 (en) | Composition for removing hangover comprising herbal mixture extract | |
KR20210147707A (en) | Composition for relieving and preventing hangover comprising Oenanthe javanica extracts | |
KR100638491B1 (en) | Compounds for relief of alcoholic hangover and drug containing the compounds | |
KR101910013B1 (en) | A composition for improving, preventing and treating of pain comprising herb extract | |
KR20090103239A (en) | A composition comprising the extract belonged to Vitidis Viniferae Radix being effective asthmatic or COPD | |
KR100768830B1 (en) | Extract of echinosophora koreensis removing hangover and having anti-oxidant activity | |
KR101393598B1 (en) | Healthy food composition for healing a hangover | |
JP2018506524A (en) | Composition for prevention, amelioration or treatment of burnout syndrome | |
KR101237215B1 (en) | Phamaceutical composition for prevention or treatment of enteritis | |
KR101528557B1 (en) | A pharmaceutical composition comprising fermented Eastern prickly pear | |
KR20090045721A (en) | Compositions for improving sleep disturbance | |
KR102080204B1 (en) | Clathrate compound of Schisandra chinensis extract and method for its production | |
KR102151003B1 (en) | Composition for eliminating hangover comprising fermented liquor of aged sprout ginseng extract as effective component | |
KR101994483B1 (en) | Pharmaceutical composition comprising the sprout extracts of zingiber officinale as an effective component for prevention or treatment of diabetes and health functional food comprising the same | |
KR101049474B1 (en) | Pharmaceutical composition for the prevention or treatment of drug addiction or schizophrenia containing cheonma extract as an active ingredient | |
KR20170073938A (en) | A composition for treating dry eye syndrome comprising a extract of Vaccinium Uliginosum as an active ingredient | |
KR20100008220A (en) | Composition for preventing and treating colon cancer containing extract of mushroom and herb medicine | |
KR102302047B1 (en) | Composition for hepatoprotective and ameliorating hangover | |
KR102353230B1 (en) | Compositions for preventing or treating respiratory diseases containing a combination of natural product extracts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |